Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Kimura MY"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ding Z, Diny NL, Gentek R, Gur-Cohen S, Kimura MY, Koay HF, Magri G, Perez-Lopez A, Pikor NB, Rodda LB
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2024 Sep 02; Vol. 221 (9). Date of Electronic Publication: 2024 Jul 31.
Autor:
Aoki A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8510, Japan., Iwamura C; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan., Kiuchi M; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Tsuji K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Sasaki A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Hishiya T; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Hirasawa R; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Kokubo K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Kuriyama S; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Onodera A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Shimada T; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Nagaoka T; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, 113-8431, Japan., Ishikawa S; Funabashi Central Hospital, Chiba, 273-8556, Japan., Kojima A; Funabashi Central Hospital, Chiba, 273-8556, Japan., Mito H; Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba, 286-0041, Japan., Hase R; Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba, 286-0041, Japan., Kasahara Y; Department of Respiratory Medicine, Eastern Chiba Medical Center, Chiba, 283-8686, Japan., Kuriyama N; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan., Nakamura S; Funabashi Municipal Medical Center, Chiba, 273-8588, Japan., Urushibara T; Kimitsu Chuo Hospital, Chiba, 292-0822, Japan., Kaneda S; Department of Gastroenterology, NHO Chiba Medical Center, Chiba, 260-8606, Japan., Sakao S; Department of Pulmonary Medicine, International University of Health and Welfare Narita Hospital, Chiba, 286-8520, Japan., Nishida O; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan., Takahashi K; Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, 113-8431, Japan., Kimura MY; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Motohashi S; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Igari H; Department of Infectious Diseases, Chiba University Hospital, Chiba, 260-8677, Japan.; COVID-19 Vaccine Center, Chiba University Hospital, Chiba, 260-8677, Japan., Ikehara Y; Department of Pathology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Nakajima H; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; COVID-19 Vaccine Center, Chiba University Hospital, Chiba, 260-8677, Japan.; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Suzuki T; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Hanaoka H; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Clinical Research Center, Chiba University Hospital, Chiba, 260-8677, Japan., Nakada TA; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Kikuchi T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, 951-8510, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. tnakayama@faculty.chiba-u.jp.; AMED-CREST, AMED, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. tnakayama@faculty.chiba-u.jp., Yokote K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan., Hirahara K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. hiraharak@chiba-u.jp.; Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan. hiraharak@chiba-u.jp.; AMED-CREST, AMED, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. hiraharak@chiba-u.jp.
Publikováno v:
Journal of clinical immunology [J Clin Immunol] 2024 Apr 22; Vol. 44 (4), pp. 104. Date of Electronic Publication: 2024 Apr 22.
Exploring the Role of Platelets in Virus-Induced Inflammatory Demyelinating Disease and Myocarditis.
Autor:
Ahmad I; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan., Omura S; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan., Sato F; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan., Park AM; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan.; Department of Arts and Sciences, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan., Khadka S; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan.; Department of Immunology, Duke University, Durham, NC 27708, USA., Gavins FNE; Department of Biosciences, Centre for Inflammation Research and Translational Medicine, College of Health and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK., Tanaka H; Division of Tumor Pathology, Department of Pathology, Asahikawa Medical University, Asahikawa 078-8510, Japan., Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Japan., Tsunoda I; Department of Microbiology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Autor:
Kanno T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Miyako K; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan.; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Endo T; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Yokoyama S; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Asou HK; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Yamada K; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana. Chuo-ku, Chiba 260-8670, Japan., Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana. Chuo-ku, Chiba 260-8670, Japan., Endo Y; Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 292-0818, Japan.; Department of Omics Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana. Chuo-ku, Chiba 260-8670, Japan.
Publikováno v:
International immunology [Int Immunol] 2024 Feb 21; Vol. 36 (3), pp. 129-139.
Autor:
Koyama-Nasu R; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Kiuchi M; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Aoki A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Wang Y; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Mita Y; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Hasegawa I; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Endo Y; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Onodera A; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Hirahara K; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Motohashi S; Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Aug 03; Vol. 11 (8), pp. 1085-1099.
Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases.
Autor:
Onodera A; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; Institute for Advanced Academic Research, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Kokubo K; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Okano M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Onoue M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Kiuchi M; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Iwamura C; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Iinuma T; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Kimura MY; Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Chiba University 'Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Japan Initiative for World-leading Vaccine Research and Development Centers, Japan Agency for Medical Research and Development (AMED), Chiba, Japan., Ebihara N; Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan., Hanazawa T; Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan., Nakayama T; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; AMED-CREST, AMED, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Electronic address: tnakayama@faculty.chiba-u.jp., Hirahara K; Department of Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; Chiba University 'Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Japan Initiative for World-leading Vaccine Research and Development Centers, Japan Agency for Medical Research and Development (AMED), Chiba, Japan. Electronic address: hiraharak@chiba-u.jp.
Publikováno v:
Pharmacology & therapeutics [Pharmacol Ther] 2023 Jul; Vol. 247, pp. 108445. Date of Electronic Publication: 2023 May 16.